Feels like your assessment might be right C2.... hence the radio silence maybe! I've been in since late 2009 and averaged down several times since. No intention of selling out now! Hopefully not long to wait until that elusive 'We've got a Partner ...' RNS turns up! GLA
""Boehringer Ingelheim VP of Respiratory Marketing Burcu Erylimaz told MM&M that her company—known in the COPD space where it co-markets Spiriva with Pfizer—is intent on deepening its respiratory presence in asthma and idiopathic pulmonary fibrosis"
Consider VRP have a partner already secured. Price X for RPL554 alone, price Y if VRP700 has success in current trial. Deal done just not signed by VRP. Small funding issue to VRP700 results sorted by small placing to "strategic investors". Ditch EFF which is surplus to requirements now.
Then out of the blue they are selected for the top 10!
One thing is for certain when that RNS arrives you will be either in or out and it would open up over 150% before being able to buy and forget any meaningful qty.
Time to accumulate and forget all the noise in between.
COPD is considered the big money earning potential for all the major pharma's. Forecast earnings run into many billions of dollars and now some believe that to be rather conservative.
SHRSRBDFRYRHLTH - If an RNS comes out like that I think we'll all break through our averages reasonably quickly! Even all us LTH's. I emailed the below address, no response yet. Did you mail Clair Poll etc directly? info@veronapharma, Cheers
Yes you would have thought a rns would have been put out if there was any thing to say do we take it from the silence that nothing has come off it ????????????????? If so then I would expect a sharp drop in sp
Funky, who did you send you mail to? They are pretty good at replying to people, but obviously they dont reply with much detail. I've had replies from Claire Poll, Chris Fielding (at WH) and I think Gemma Howe and Lui Francozi also replied back in the day to my e-mails.
I havent been on over the last couple of days because i've been on the road, but i must admit that i would have thought that a little bit of interest might have started stirring in us following the conference.
Personally hoping for an RNS that states something like "Following on from discussions during 2013 with potential pharma groups and detailed partner meetings which were held during the recent TAC conference in Boston, that VRP can confirm that they are now in advanced talks to partner their lead drug RPL554 and also VRP700. As indicated in previous announcements VRP have always looked to maximise shareholder value. A further detailed announcement will be made shortly......that would wake a few people up and get the SP moving!!! Well i can but hope/dream!!
I emailed VRP asking if there will be an update regards any progress from conference. Also questions about Darwin and current cash reserves. If I get a reply ( which I doubt! ) I will post it. I think they maybe in a closed period.........
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.